Abstract
Intestinal trefoil factor (ITF) is a novel polypeptide with potential pharmacological value for the prevention and healing of tissue injury; however, poor production capacity limits its clinical application. Chitosan, as a non-viral vehicle, has been successfully used in gene delivery for its intrinsic characteristics. In this context, we prepared chitosan nanoparticles enwrapping ITF cDNA and investigated its size, zeta potential, stability, release profiles, loading efficiency and loading capacity. Gene transfer capability was assessed in HEK293 cells. The data revealed that the chitosan/DNA nanoparticles were successfully prepared with sizes less than 500 nm and positive zeta potentials. The nanoparticles could protect DNA from nuclease degradation, and release profiles of DNA were dependent on N/P ratios. In addition, transfection efficiency of chitosan/DNA nanoparticles was equivalent to Lipofectamine (TM). Collectively, the results suggest that chitosan/DNA nanoparticles could be a promising method for ITF gene therapy.
Similar content being viewed by others
References
Borchard G (2001) Chitosans for gene delivery. Adv Drug Deliv Rev 52:145–150
Oligino TJ, Yao Q, Ghivizzani SC, Robbins P (2000) Vector systems for gene transfer to joints. Clinical Orthopaedics 379:S17–S30
Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR, Grossman JM, Wilson JM, Johnson LG, Boucher RC (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823–831
Ferber D (2001) Gene therapy: safer and virus-free? Science 294:1638–1642
Bozkir A, Saka OM (2004) Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv 11:107–112
Onishi H, Machida Y (1999) Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175–182
Romoren K, Thu BJ, Evensen O (2002) Immersion delivery of plasmid DNA II. A study of the potentials of a chitosan based delivery system in rainbow trout (Oncorhynchus mykiss) fry. J Controlled Release 85:215–225
Rao SB, Sharma CP (1997) Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 34:21–28
Fang N, Chan V, Mao HQ, Leong KW (2001) Interactions of phospholipids bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules 2:1161–1168
Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70:399–421
Chen J, Yang WL, Li G, Qian J, Xue JL, Fu SK, Lu DR (2004) Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J Gastroenterol 10:112–116
Jayakumar R, Prabaharan M, Nair SV, Tamura H (2010) Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv 28:142–150
Weecharangsan W, Opanasopit P, Ngawhirunpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Lee RJ (2008) Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm 348:161–168
Thim L, Woldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK (1995) Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 34:4757–4764
Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK (1995) Trefoil peptide protection of intestinal epithelial barrier function-cooperative interaction with mucin glycoprotein. Gastroenterology 109:516–523
Mashimo H, Wu DC, Podolskym DK, Fishman MC (1996) Science 274:262–265
Turan SO, Aral C, Kabasakal L, Uysal MK, Akbuga J (2003) Coencapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J Pharm Pharmaceut Sci 6:27–32
Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419
Jayakumar R, Prabaharan M, Nair SV, Tokura S, Tamura H, Selvamurugan N (2010) Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications. Prog Mater Sci 55:675–709
Zhao Y, Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L (2010) Synthesis and characterization of graft copolymer of chitosan and polyethylene glycol. Mol Biol Rep. doi:10.1007/s11033-010-0381-y
Sato T, Ishii T, Okata Y (2001) In vitro gene delivery mediated by chitosan. Effect of pH, serum and molecular mass of chitosan on the transfection efficiency. Biomaterials 22:2075–2080
Kiang T, Wen J, Lim HW, Leong KW (2004) The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 25:5293–5301
Acknowledgments
This study was supported by the Scientific Research Funds of Nanjing Military Command (09Z007), State Key Lab Funding in China (SKLZZ200905), and Key Project on Advanced Clinical Technology for Military Hospital (2010gxjs068).
Author information
Authors and Affiliations
Corresponding author
Additional information
Yong Sun and Shuai Zhang contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sun, Y., Zhang, S., Peng, X. et al. Preparation, characterization and transfection efficacy of chitosan nanoparticles containing the intestinal trefoil factor gene. Mol Biol Rep 39, 945–952 (2012). https://doi.org/10.1007/s11033-011-0820-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-0820-4